8AG-13072-18841
5 vaccinations
6 coded responses
36 check-ins
5 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 242 / VA
- Registered
- 2021-01-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-21
Registered in v-safe
-
2021-01-21
Dose 1 — Pfizer-BioNTech
- 2021-01-22
- 2021-01-23
- 2021-01-24
-
2021-01-25
Survey response — days 1–6 daily, dose 1MedDRA: Rash — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: Been present for several days. Not sure the rash is associated with the injection. Slight rash on feet and lower legs.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-26
Survey response — days 1–6 daily, dose 1MedDRA: Unevaluable event — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: Rash seems improved today with over-the-counter lotion. Not certain it is related to vaccination.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-27
- 2021-01-28
- 2021-02-04
-
2021-02-11
Dose 2 — Pfizer-BioNTech
-
2021-02-11
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-13
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-03-25
- 2021-05-13
-
2021-08-12
Survey response — 6 months, dose 2MedDRA: Cough, Lacrimation increased, Ocular hyperaemia, Office visit, Periorbital swelling, Respiratory tract congestion — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: An weepy, reddened eye accompanied by enlarged area beneath the eye. A bit of dry cough and congestion as well. Addressed by local urgent care. Mostly resolved now.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-12
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-20
-
2021-10-26
Dose 3 — Pfizer-BioNTech
-
2022-02-11
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-02-11
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-02-14
Call successfulDoes not wish to fill out VAERS report
-
2022-05-24
Dose 4 — Pfizer-BioNTech
-
2022-10-07
Dose 5 — Pfizer-BioNTech
-
2022-10-07
Health check-in — day 0, dose 5Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2022-10-09
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-10-11
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-10-12
- 2022-10-13
- 2022-10-14
- 2022-10-21
- 2022-10-28
-
2022-11-04
Survey response — day 28, dose 5MedDRA: Nasopharyngitis, Respiratory tract congestion, SARS-CoV-2 test negative, Sinus congestion — Feeling: PoorFree text: Sinus and chest congestion. Probably a cold. Took a COVID test at home. Negative.MedDRA releases: 2024-11 · check-in free text available
- 2022-11-12
- 2022-11-18
- 2023-01-08
-
2023-04-07
Survey response — 6 months, dose 5MedDRA: Knee arthroplasty — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-21 | Pfizer-BioNTech | |
| 2 | 2021-02-11 | Pfizer-BioNTech | |
| 3 | 2021-10-26 | Pfizer-BioNTech | No |
| 4 | 2022-05-24 | Pfizer-BioNTech | No |
| 5 | 2022-10-07 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Been present for several days. Not sure the rash is associated with the injection. Slight rash on feet and lower legs.
Systemic reaction (other): Rash seems improved today with over-the-counter lotion. Not certain it is related to vaccination.
Release 9 — 6 months, dose 2
Symptoms: An weepy, reddened eye accompanied by enlarged area beneath the eye. A bit of dry cough and congestion as well. Addressed by local urgent care. Mostly resolved now.
Release 11 — 12 months, dose 2
Symptoms: COVID
Release 12 — day 28, dose 5
Symptoms: Sinus and chest congestion. Probably a cold. Took a COVID test at home. Negative.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Knee arthroplasty | · | · | ✓ |
| SD | Lacrimation increased | ✓ | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Ocular hyperaemia | ✓ | · | ✓ |
| SD | Office visit | ✓ | · | ✓ |
| SD | Periorbital swelling | ✓ | · | ✓ |
| SD | Respiratory tract congestion | ✓ | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release